EyeGate Pharmaceuticals Earning Date (EYEG)

USA |NASDAQ |USD

EYEG Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 23, 2022 Dec 2021 $-0.28 - $-0.52
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 23, 2022 Dec 2021 $0.00 - $12.06K

Eyegate Pharmaceuticals's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 2021.

EYEG Earnings Date & History Chart

EYEG Earnings & Revenue Forecast

EYEG Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.90 $-0.94 $-0.81

EYEG Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.90 $-0.87 $-1.50

EYEG Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $2.77M $0.00 $8.30M

EYEG Earnings Date & Revenue History

EYEG Earnings History

|
Show More
Show More

EYEG Revenue History

|
Show More
Show More

Eyegate Pharmaceuticals Next Earnings Date & Report

EYEG Next Earnings Date & Report Preview: Dec 2021 (FQ)

EYEG's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Eyegate Pharmaceuticals's next quarterly earnings is $-0.28, with a low EPS estimation of $-0.36, and a high estimation of $-0.23.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.28, the last 2 month trend is $-0.24, and the 3 month trend is $-0.39.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Eyegate Pharmaceuticals Previous Earnings Dates & Reports

EYEG Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Eyegate Pharmaceuticals's previous earnings date was Nov 8, 2021 for its fiscal quarter ended Sep 30, 2021.

EYEG Previous Earnings Date & Report Recap: Dec 2020 (FY)

Eyegate Pharmaceuticals's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

EYEG's earnings per share (EPS) was $-1.77, beating the consensus analysts forecast of $-2.02 by -12.38% , and higher than the previous year's EPS (Dec 2019) by -25.00%.

Revenues were $12.06K, worse than the forecast of $30.00K by -59.80%, and down by -99.55% from previous year's revenue.

The company reported a net income of $-8.09M.

Eyegate Pharmaceuticals reported a free cash flow of $-7.45M for its fiscal year, compared to $-8.15M a year ago.

The company ended the fiscal year with $326.49K in total debt, an increase of 289.02% compared to the previous year.